Omadacycline in community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections: a profile of its use Yvette N. LambKatherine A. Lyseng-Williamson Adis Drug Q&A 06 May 2019 Pages: 305 - 314
K-haler® breath-triggered inhaler: a profile of the properties of the device Emma D. DeeksKatherine A. Lyseng-Williamson Adis Device Q&A Open access 06 May 2019 Pages: 315 - 320
Take a multifaceted approach when treating onychomycosis Adis Medical Writers Disease Management 20 May 2019 Pages: 321 - 325
Minimize exposure to antidopaminergic drugs whenever possible to reduce the risk of drug-induced parkinsonism and tardive dyskinesia Adis Medical Writers Drug Reactions and Interactions 28 May 2019 Pages: 326 - 331
Effect of GSTP1 polymorphism on efficacy and safety of cyclophosphamide aggressive therapy in lupus nephropathy patients K. Khine ThuAye Aye LwinNang Hla Hla Win Original Research Article 06 May 2019 Pages: 334 - 340
Assessment of anticoagulation management in outpatients attending a warfarin clinic in Windhoek, Namibia Lauren J. JonkmanMarvelous P. GwanyanyaBonifasius S. Singu Original Research Article 25 April 2019 Pages: 341 - 346
No difference in relevant potential allergens in SPF-containing facial moisturizers: implications in frontal fibrosing alopecia Dustin H. MarksAthena Manatis-LornellMaryanne M. Senna Short Communication 08 May 2019 Pages: 347 - 349
Correction to: Midazolam oral solution (Ozalin®): a profile of its use for procedural sedation or premedication before anaesthesia in children Katherine A. Lyseng-Williamson Correction Open access 25 May 2019 Pages: 350 - 350